Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1964-1989
Open Access | Times Cited: 11

Showing 11 citing articles:

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Obesity-Mediated Intratumoral Innervation Increases Pancreatic Cancer Tumorigenesis
Shyamananda Singh Mayengbam, Aftab Alam, Matthew T. Witkowski, et al.
(2025)
Closed Access
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
Emily L Lasse-Opsahl, Ivana Barravecchia, Elyse McLintock, et al.
JCI Insight (2025) Vol. 10, Iss. 1
Open Access
Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer
He Xiao, Xi Cheng, Zhun Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma
Jiayu Jiang, H. Chen, Chunxing Zhao, et al.
Cancer Letters (2025), pp. 217584-217584
Closed Access
Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression
Yunxiao Ge, Veronica Janson, Zigang Dong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189296-189296
Open Access
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS G12D inhibitor in KRAS LUAD
Fernando C. Baltanás, Maximilian Kramer‐Drauberg, Rósula García‐Navas, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Stromal KITL/SCF promotes pancreas tissue homeostasis and restrains tumor progression
M. Kathrina Oñate, Chet Oon, Sohinee Bhattacharyya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Pancreatic Cancer-Associated Fibroblasts: Where do we go from here?
Eileen S. Carpenter, Débora B. Vendramini‐Costa, Marie C. Hasselluhn, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3505-3508
Closed Access | Times Cited: 1
CAFomics: convergence to translation for precision stroma approaches
Ian C. McCabe, Xianlu L. Peng, Joseph F. Kearney, et al.
Carcinogenesis (2024)
Closed Access
Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer
Yanli Guo, Yu Jin, Jie Gao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1696-1696
Open Access
Page 1

Scroll to top